Kölling K, Hoenle R, Korsten F W
Radiologe. 1977 Feb;17(2):70-3.
The new substance Iodoxamate (Endomirabil) is a hepatotropic contrast medium. In a clinical comparative study, the contrast of the biliary ducts and gall bladder is equivalent compared with Ioglycamid (Bilivistan). Assuming equal conditions of injection and in conformity with animal experimental studies, the rate of side effects of Iodoxamate is distinctly lower than that of the referring substance Iolgycamid (Bilivistan).
新型物质碘多酰胺（恩多米拉比尔）是一种亲肝性造影剂。在一项临床对比研究中，与碘甘米德（必利维斯坦）相比，其对胆管和胆囊的造影效果相当。在注射条件相同且符合动物实验研究的情况下，碘多酰胺的副作用发生率明显低于对照物质碘甘米德（必利维斯坦）。
